Alessandro D. Santin
Yale University(US)
Publications by Year
Research Areas
Ovarian cancer diagnosis and treatment, HER2/EGFR in Cancer Research, Endometrial and Cervical Cancer Treatments, Monoclonal and Polyclonal Antibodies Research, Immunotherapy and Immune Responses
Most-Cited Works
- → Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer(2019)825 cited
- → Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study(2019)800 cited
- → Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu(2018)512 cited
- → Tumor-associated macrophages drive spheroid formation during early transcoelomic metastasis of ovarian cancer(2016)434 cited
- → Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket trial(2021)355 cited
- → Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma(2013)334 cited